|
|
|
| Control API Impurities To Achieve Therapeutic Safety For Patients | Article | By Robert Hughes, Grace Fine Chemical Manufacturing Services | In your CDMO search, prioritize finding a partner who recognizes impurity control as a critical component of patient-focused drug development and offers the necessary capabilities to ensure safety and efficacy. |
|
|
|
|
| Four Reasons For The Rise In Blister Packaging | Article | By Yves Massicotte, Ropack Pharma Solutions | Discover the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth. |
|
|
|
| Empowering A New Era Of Patient-Centric Medicines | Podcast | Nanoform | Delve into the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients. |
|
|
|
| High Shear Mixer Considerations For The Cannabis Industry | Article | By Christine Banaszek, Charles Ross and Son Company | The growing demand for cannabis-infused products provides an opportunity and a challenge for manufacturers. Gain insights into high shear mixers and how they can be used to create these products. |
|
|
|
|
| The Scalability Of Depth Filters For CHO Cell Culture Clarification | Poster | By Rajeshwar Chinnawar, Bridget Marriott, Luke McCarney, and Nick Marchand, Cytiva | Clarification using depth filtration is standard in monoclonal antibody (mAb) manufacturing. Here, we showcase the scalability of disposable depth filters, demonstrating their effectiveness. |
|
|
|
| Fundamentals Of Particle Size Analysis | Q&A | Catalent | Uncover the importance of particle size characterization and the advanced analytical techniques employed to assess micronized particles effectively. |
|
|
|
|
By Andy O’Connor, ERA Sciences | Statistical analysis provides a backbone for establishing critical process parameters and offers evidence of process validation for regulatory submissions. Learn how to ensure data integrity and reliability for the statistical analysis of GxP data. | |
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|